Compounds > phenyl acetate
Page last updated: 2024-08-23

phenyl acetate and Thromboembolism, Venous

phenyl acetate has been researched along with Thromboembolism, Venous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Cummings, TH; Hardin, JW; Magagnoli, J; Sutton, SS1
But, A; Haukka, J; Heikinheimo, O; Latvala, A; Partonen, T; Toffol, E1

Other Studies

2 other study(ies) available for phenyl acetate and Thromboembolism, Venous

ArticleYear
Leukotriene receptor antagonism with montelukast as a possible therapeutic for venous thromboembolism prophylaxis: An observational study.
    Prostaglandins & other lipid mediators, 2022, Volume: 161

    Topics: Acetates; Cyclopropanes; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Receptors, Leukotriene; Retrospective Studies; Sulfides; Venous Thromboembolism

2022
Systemic hormonal contraception and risk of venous thromboembolism.
    Acta obstetricia et gynecologica Scandinavica, 2022, Volume: 101, Issue:8

    Topics: Acetates; Aged; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Estradiol; Estrogens; Female; Humans; Progesterone Congeners; Progestins; Prospective Studies; Venous Thromboembolism

2022